Evoleen Invest AG

Overview

Evoleen Invest AG is a Swiss venture capital firm specializing in health tech and digital health investments. The firm focuses on seed and start-up stages, providing equity financing to companies in the medical, life sciences, and health-related sectors. Their geographical focus includes Switzerland, Europe, and worldwide markets. Evoleen Invest AG manages capital between CHF 20 million and CHF 50 million, with investments ranging from CHF 0.5 million to CHF 2.5 million. The firm has a portfolio of 8 to 25 companies, including SIVA Health AG, Collabree AG, Carity Care AG, CITUS Health AG, and Hello Mirrors GmbH. Evoleen Invest AG was established in 2019 and is headquartered in Zürich, Switzerland. The company's mission is to co-create and scale tech-driven ventures in collaboration with major pharmaceutical and medtech companies, addressing challenges from diagnosis and clinical trials to therapy and access to care. Their investment strategy emphasizes a disruptive fee-for-service and milestone-based approach, aligning incentives for real impact. Evoleen Invest AG is committed to transforming healthcare by supporting innovative health solutions and smart medical devices.